pH-Responsive Micelle Sequestrant Polymers Inhibit Fat Absorption.

Area of Science:

• Polymer Chemistry
• Gastroenterology
• Pharmacology

Background:

• Current obesity treatments have limitations including side effects and poor patient compliance.
• There is a need for novel, safer, and more effective antiobesity therapeutics.
• Targeting lipid absorption presents a potential strategy for weight management.

Purpose of the Study:

• To design and engineer a new class of orally acting pharmaceutical agents, micelle sequestrant polymers (MSPs).
• To evaluate the pH-triggered lipid micelle sequestration and inhibition of lipid absorption by MSPs.
• To assess the in vivo efficacy of MSPs in enhancing fecal elimination of triglycerides and bile acids.

Main Methods:

• Synthesis of MSPs from poly(2-(diisopropylamino)ethyl methacrylate) and poly(2-(dibutylamino)ethyl methacrylate).
• In vitro assessment of MSP solubility, pH-triggered flocculation, and sequestration capacity for bile acids and triglycerides.
• In vivo studies in animal models to measure fecal elimination of triglycerides and bile acids after oral MSP administration.

Main Results:

• MSPs demonstrated pH-dependent solubility, becoming insoluble around pH 7.2 and 6.1.
• In vitro studies showed substantial and rapid sequestration of bile acids and triglycerides by MSPs.
• Oral MSP administration significantly increased fecal triglyceride elimination by 9-10 times compared to controls, with no effect on bile acid absorption.

Conclusions:

• MSPs represent a novel class of orally acting agents for obesity management.
• The pH-triggered micelle sequestration mechanism effectively inhibits dietary triglyceride absorption.
• MSPs offer a promising alternative to existing antiobesity therapies by preventing excess caloric intake.